Nisa Investment Advisors
CTKB icon

Nisa Investment Advisors’s Cytek Biosciences CTKB Stock Holding History

Nisa Investment Advisors’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47K Sell
558
-3,196
-85% -$13.6K ﹤0.01% 2729
2026
Q1 		$16.4K Buy
3,754
+101
+3% +$477 ﹤0.01% 2084
2025
Q4 		$18.4K Sell
3,653
-1,227
-25% -$5.7K ﹤0.01% 1973
2025
Q3 		$16.9K Buy
4,880
+327
+7% +$1.23K ﹤0.01% 2070
2025
Q2 		$15.5K Buy
4,553
+2,993
+192% +$9.97K ﹤0.01% 2065
2025
Q1 		$6.26K Sell
1,560
-639
-29% -$3.31K ﹤0.01% 2199
2024
Q4 		$14.3K Buy
2,199
+183
+9% +$1.09K ﹤0.01% 2043
2024
Q3 		$11.2K Buy
2,016
+267
+15% +$1.51K ﹤0.01% 2079
2024
Q2 		$9.76K Buy
1,749
+334
+24% +$2.01K ﹤0.01% 2161
2024
Q1 		$9.49K Buy
1,415
+60
+4% +$475 ﹤0.01% 2047
2023
Q4 		$12.4K Sell
1,355
-6,505
-83% -$40.9K ﹤0.01% 1993
2023
Q3 		$43.4K Buy
7,860
+6,600
+524% +$52.9K ﹤0.01% 1766
2023
Q2 		$10.8K Sell
1,260
-830
-40% -$7.45K ﹤0.01% 2244
2023
Q1 		$19K Buy
2,090
+50
+2% +$538 ﹤0.01% 2022
2022
Q4 		$21K Sell
2,040
-41
-2% -$551 ﹤0.01% 2043
2022
Q3 		$32K Buy
2,081
+381
+22% +$4.95K ﹤0.01% 1903
2022
Q2 		$18K Buy
+1,700
New +$16.9K ﹤0.01% 2069

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nisa Investment Advisors's CTKB Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Cytek Biosciences (CTKB) stake by 85% in Q2 2026, selling an estimated $13.6K and leaving 558 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Nisa Investment Advisors first reported a position in CTKB in Q2 2022 and has held it in 17 quarters since. The position peaked at $43.4K in Q3 2023. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Nisa Investment Advisors held 558 shares of Cytek Biosciences worth $2.47K as of Q2 2026.
  • Nisa Investment Advisors sold 3,196 Cytek Biosciences shares in Q2 2026, an estimated $13.6K.
  • Cytek Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2729 holding.
  • Nisa Investment Advisors first reported a position in Cytek Biosciences in Q2 2022 and has held it in 17 quarters since.
  • Nisa Investment Advisors's Cytek Biosciences position peaked at $43.4K in Q3 2023.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.